EpiAxis highlights – April 2022

EpiAxis highlights – April 2022

April was an exciting month for EpiAxis Therapeutics, with Dr Darren Saunders joining the company as inaugural Chief Science Officer and CEO Dr Jeremy Chrisp updating investors in Australia and China on the company's progress in the epigenetic space. Dr Saunders...

read more
EpiAxis Therapeutics presents at ACCESS CHINA

EpiAxis Therapeutics presents at ACCESS CHINA

EpiAxis Therapeutics was thrilled to attend and present at the ACCESS CHINA Biotech Forum Spring Showcase 2022 earlier this month. ACCESS CHINA Biotech Forum is one of the largest corporate access events in China. It provides opportunities for business development,...

read more

 

Professor Sudha Rao